Kraig Biocraft Laboratories In Stock Price, News & Analysis

Kraig Biocraft Laboratories (KBLB) has been granted a business license to operate in Lam Dong Province, Vietnam, enhancing its efforts in spider silk production. This expansion leverages the region's ideal climate for silkworm rearing and existing silk production infrastructure. Notably, the Lam Dong Agro-Forestry Research Experiment Center is instrumental in boosting mulberry yields, which Kraig Labs has started utilizing, showing a doubled production capacity. The company maintains its headquarters in Quang Nam, where it produces proprietary silkworm eggs. COO Jon Rice expressed optimism about the integration of their technology into Vietnamese silk production.

Kraig Biocraft Laboratories (KBLB) has released a new video showcasing its recombinant spider silk production operations, providing insights into its U.S. R&D and Vietnam quality control labs. The video emphasizes the work of its dedicated researchers in creating cost-effective and eco-friendly spider silk products. COO Jon Rice highlighted the team's efforts in developing advanced materials. Future videos will explore breeding operations and the team behind these innovations.

Kraig Biocraft Laboratories (OTCQB: KBLB) attended the SaigonTex exhibition in Vietnam, marking its first major textile industry event since 2019 due to COVID-19. The SpydaSilk brand team aimed to expand its supplier network, focusing on creating unique yarns and fabrics from the company's recombinant spider silk technologies. COO Jon Rice expressed enthusiasm about the exhibition's return and its networking opportunities. The company is also set to release a new behind-the-scenes video next week about its spider silk production, emphasizing ongoing R&D efforts.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) released a video showcasing its advanced silkworm breeding facility in Vietnam. This facility is dedicated to producing eco-friendly spider silk and is expected to meet production demands through 2025.

The video marks the beginning of a series aimed at providing insights into the Company's recombinant spider silk production operations. Kraig Labs believes this facility is one of the most advanced in the world, enhancing their capacity for cost-effective production. Future videos will explore R&D labs and breeding operations.

Kraig Biocraft Laboratories, Inc. (KBLB) has signed its first third-party production contract for large-scale manufacturing of recombinant spider silk. Operations are set to begin immediately, with expectations of producing hundreds of kilograms per month and possibly reaching multiple metric tons by Q1 2023. The contractor, already equipped with Kraig's proprietary technology, will undergo a 90-day ramp-up for initial deliveries. Kraig Labs will gain minority ownership in the production facility, ensuring oversight of financial records and operations as they aim to deliver eco-friendly spider silk to the market.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has announced the successful development of new hybrid Dragon Silk^TM silkworms aimed at enhancing large-scale production in Vietnam. These new breeds are designed to produce larger cocoons and longer silk filaments, which will significantly lower production costs and improve throughput. This initiative builds on the company's hybridization program initiated in 2018, resulting in silk cocoons that are 30-100% larger than traditional non-hybrid silkworms, thus facilitating a more consistent production platform.

Kraig Biocraft Laboratories (KBLB) has selected a high-quality garment manufacturer, in collaboration with its partner Kings Group, to produce its first apparel line using Spydasilk's^TM exclusive spider silk materials. The chosen manufacturer has over 20 years of experience and strong connections within Vietnam's textile supply chain, enabling it to deliver on the vision for the brand. Kraig Labs is simultaneously developing a product launch plan that includes marketing and distribution strategies, with expectations for further updates on production and market advancements.

Kraig Labs has successfully completed its third-party pilot production of recombinant spider silk, enabling the critical next phases of its business plan. The program exceeded expectations, leading to negotiations for a five-year production contract. Key management reviewed pilot production in Vietnam, with plans to produce metric tons of spider silk. The company aims to enhance production quality and is entering a phase of rapid production expansion in collaboration with subcontractors. Updates on production and development are expected soon.

Kraig Biocraft Laboratories (OTCQB: KBLB) announces a senior management visit to Vietnam for production expansion and market development. Key activities include meetings with government officials to secure additional lands and agreements for silk production, potentially scaling to 200 metric tons annually. The COO, Jon Rice, will also finalize launching the Spydasilk brand with joint venture partners. The company is enhancing its Vietnamese subsidiary, Prodigy Textiles, through advanced training and technology transfers to improve production capabilities.